Back to Search
Start Over
Real-Life Efficacy and Safety of Vemurafenib Plus Rituximab (V+R) in Relapsed or Refractory Hairy Cell Leukemia: A Multi-Center Retrospective Study (HCL-PG03R)
- Source :
- Blood; November 2023, Vol. 142 Issue: 1, Number 1 Supplement 1 p3027-3027, 1p
- Publication Year :
- 2023
-
Abstract
- BACKGROUND
Details
- Language :
- English
- ISSN :
- 00064971 and 15280020
- Volume :
- 142
- Issue :
- 1, Number 1 Supplement 1
- Database :
- Supplemental Index
- Journal :
- Blood
- Publication Type :
- Periodical
- Accession number :
- ejs64701088
- Full Text :
- https://doi.org/10.1182/blood-2023-178648